Cargando…
Salicylato[tris(N-methylbenzimidazol-2-ylmethyl)amine]zinc(II) perchlorate dimethylformamide sesquisolvate
In the title complex, [Zn(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·1.5C(3)H(7)NO, the Zn(II) atom is five-coordinated by four N atoms from a tris(N-methylbenzimidazol-2-ylmethyl)amine ligand and one O atom from a salicylate ligand in a distorted trigonal-bipyramidal geometry (τ parameter = 0.84), wit...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915077/ https://www.ncbi.nlm.nih.gov/pubmed/21200485 http://dx.doi.org/10.1107/S1600536807064902 |
Sumario: | In the title complex, [Zn(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·1.5C(3)H(7)NO, the Zn(II) atom is five-coordinated by four N atoms from a tris(N-methylbenzimidazol-2-ylmethyl)amine ligand and one O atom from a salicylate ligand in a distorted trigonal-bipyramidal geometry (τ parameter = 0.84), with approximate molecular C (3) symmetry. One dimethylformamide molecule lies on a general position and is disordered over two coplanar orientations with equal occupancy. A second dimethylformamide molecule is disordered about a twofold rotation axis. |
---|